Steven E. Vogl
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies 7
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 13
- Oncology top 5%
- Cancer Treatment and Pharmacology 6
- Metal complexes synthesis and properties 4
-
- Lung Cancer Treatments and Mutations 8
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments 4
-
- Chemotherapy-induced organ toxicity mitigation 5
-
- Testicular diseases and treatments 4
- Co-authors
- Barry H. KaplanEdward S. GreenwaldRichard H. CreechDavid S. EttingerJohn C. RuckdeschelBernard A. MasonR JossDianne M. Finkelstein
- Partner nations
- United StatesUnited KingdomSouth Africa
In The Last Decade
Steven E. Vogl
50 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 85
- Otorhinolaryngology 250
- Reproductive Medicine 276
- Oncology 749
- Pulmonary and Respiratory Medicine 554
- Obstetrics and Gynecology 103
Countries citing papers authored by Steven E. Vogl
This map shows the geographic impact of Steven E. Vogl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven E. Vogl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven E. Vogl more than expected).
Fields of papers citing papers by Steven E. Vogl
This network shows the impact of papers produced by Steven E. Vogl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven E. Vogl. The network helps show where Steven E. Vogl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Steven E. Vogl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2017 | 5 | |
| 3 | 2012 | 0 | |
| 4 | 1998 | 9 | |
| 5 | 1998 | 14 | |
| 6 | 1992 | 50 | |
| 7 | 1991 | 13 | |
| 8 | 1991 | 21 | |
| 9 | 1990 | 31 | |
| 10 | 1989 | 4 | |
| 11 | 1988 | 46 | |
| 12 | Doxorubicin and cisplatin in the treatment of advanced mixed mesodermal uterine sarcoma. | 1984 | 12 |
| 13 | 1984 | 6 | |
| 14 | 1984 | 17 | |
| 15 | 1983 | 0 | |
| 16 | 1982 | 10 | |
| 17 | 1981 | 15 | |
| 18 | 1980 | 3 | |
| 19 | 1980 | 57 | |
| 20 | 1976 | 51 |
About Steven E. Vogl
Steven E. Vogl is a scholar working on Otorhinolaryngology, Reproductive Medicine, Microbiology, Oncology and Obstetrics and Gynecology, having authored 55 papers that have together received 1.4k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (13 papers), Lung Cancer Treatments and Mutations (8 papers), Head and Neck Cancer Studies (7 papers), Cancer Treatment and Pharmacology (6 papers), Chemotherapy-induced organ toxicity mitigation (5 papers), Testicular diseases and treatments (4 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Metal complexes synthesis and properties (4 papers). The work is most often cited by research in Otorhinolaryngology (250 citations), Reproductive Medicine (276 citations), Oncology (749 citations), Pulmonary and Respiratory Medicine (554 citations) and Obstetrics and Gynecology (103 citations). Steven E. Vogl has collaborated with scholars based in United States, United Kingdom and South Africa. Frequent co-authors include Barry H. Kaplan, Edward S. Greenwald, Richard H. Creech, David S. Ettinger, John C. Ruckdeschel, Bernard A. Mason, R Joss, Dianne M. Finkelstein, Vicki Seltzer and Fernando Camacho. Their work appears in journals such as Cancer, Gynecologic Oncology, Journal of Clinical Oncology, Investigational New Drugs and The Laryngoscope.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.